Weipu Mao

7PUBLICATIONS
29CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 23, 2026
SPP1+ macrophage-induced CD74+ tumor cells promote adrenocortical carcinoma tumor thrombus via the SPP1/CD44/JAK/STAT signaling.

|Sep 18, 2025
CircPVT1 Promotes Lung Metastasis and Tumor Progression in Renal Cell Carcinoma by Encoding the cP104aa Peptide and Targeting EIF4A3.

Houliang Zhang, Tao Tao, Jie Ji

|Jul 07, 2025
YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.

Wenchao Li, SaiSai Chen, Jian Lu

|Nov 04, 2024
Research progress of MUC1 in genitourinary cancers.

Weipu Mao, Houliang Zhang, Keyi Wang

|Apr 15, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.

Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya

|Nov 27, 2023
Cisplatin induces acute kidney injury by downregulating miR-30e-5p that targets Galnt3 to activate the AMPK signaling pathway.

Weipu Mao, Lei Zhang, Yiduo Wang

Pageof 2

Frequent Collaborators

2 joint publications

Keyi Wang

1 joint publications

Yongzhe Gu

1 joint publications

Jinliang Ni

1 joint publications

Houliang Zhang